Follow
Alan S. Coates
Alan S. Coates
Clinical Professor, School of Publc Health & NHMRC Clinical Trials Centre, University of Sydney
Verified email at ibcsg.org - Homepage
Title
Cited by
Cited by
Year
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 366 (9503), 2087-2106, 2005
61542005
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A Goldhirsch, WC Wood, AS Coates, RD Gelber, B Thürlimann, HJ Senn
Annals of oncology 22 (8), 1736-1747, 2011
48142011
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
42932013
Tamoxifen for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 351 (9114), 1451-1467, 1998
40941998
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
22252015
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 379 (9814), 432-444, 2012
21932012
Polychemotherapy for early breast cancer: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 352 (9132), 930-942, 1998
21571998
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
Breast International Group (BIG) 1-98 Collaborative Group
New England Journal of Medicine 353 (26), 2747-2757, 2005
19632005
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009
A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn
Annals of oncology 20 (8), 1319-1329, 2009
19522009
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …
P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews …, 2014
1856*2014
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma
MR Middleton, JJ Grob, N Aaronson, G Fierlbeck, W Tilgen, S Seiter, ...
Journal of Clinical Oncology 18 (1), 158-158, 2000
16572000
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005
A Goldhirsch, JH Glick, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 16 (10), 1569-1583, 2005
15802005
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A Goldhirsch, WC Wood, RD Gelber, AS Coates, B Thürlimann, HJ Senn, ...
Annals of oncology 18 (7), 1133-1144, 2007
13162007
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
12802013
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
12742015
On the receiving end—patient perception of the side-effects of cancer chemotherapy
A Coates, S Abraham, SB Kaye, T Sowerbutts, C Frewin, RM Fox, ...
European Journal of Cancer and Clinical Oncology 19 (2), 203-208, 1983
11881983
Meeting highlights: international consensus panel on the treatment of primary breast cancer
A Goldhirsch, JH Glick, RD Gelber, AS Coates, HJ Senn
Journal of clinical Oncology 19 (18), 3817-3827, 2001
1164*2001
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98
AS Coates, A Keshaviah, B Thürlimann, H Mouridsen, L Mauriac, ...
Journal of clinical oncology 25 (5), 486-492, 2007
11482007
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
RC Coombes, LS Kilburn, CF Snowdon, R Paridaens, RE Coleman, ...
The Lancet 369 (9561), 559-570, 2007
10912007
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10402019
The system can't perform the operation now. Try again later.
Articles 1–20